Ratnakar Securities

Mobile Trading
COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE1735.454.25 (+0.25 %)
PREV CLOSE ( ) 1731.20
OPEN PRICE ( ) 1733.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 106081
TODAY'S LOW / HIGH ( )1705.60 1740.60
52 WK LOW / HIGH ( )1376.75 1960.2
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-03 1993
Management Info
Dilip S Shanghvi - Chairman Dilip S Shanghvi - Managing Director
Registered Office

Address Sun Pharma Advanced Research Centre (S P A R C),Tandalja, ,
Vadodara,
Gujarat-390012

Phone 0265- 5515500 / 5515600 / 5515700

Email secretarial@sunpharma.com

Website www.sunpharma.com

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
18Mar Sun Pharmaceutical Industries’ arm a
Sun Pharmaceutical Industries’ subsidiary -- TARO Pharmaceuticals Inc...
17Mar Sun Pharma’s arm recalls 9,840 bottl
Sun Pharmaceutical Industries’ subsidiary -- Sun Pharmaceutical Indust..
10Mar Sun Pharmaceutical Industries informs
Sun Pharmaceutical Industries has informed that it enclosed its press re..
10Mar Sun Pharma to acquire Checkpoint Thera
Sun Pharmaceutical Industries and Checkpoint Therapeutics, Inc. (Checkpo..
10Mar Sun Pharma rises on plans to acquire C
Sun Pharmaceutical Industries is currently trading at Rs. 1612.90, up by..
MORE
Financials
in Millions
QTR Dec 24 ANNUAL 24
Net Profit11810.528581.8
Gross Profit 12649.3 34496.5
Operating Profit 17718.660533.7
Net Sales 61918.1202751.7
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
up  30730.65 (0.48%)
M.Cap ( in Cr)65300.49
Procter&Gamble Healt (BSE)
up  5142.30 (2.90%)
M.Cap ( in Cr)8535.90
Astrazeneca Pharma I (BSE)
up  8606.35 (1.32%)
M.Cap ( in Cr)21515.88
Neuland Laboratories (BSE)
up  12076.95 (0.46%)
M.Cap ( in Cr)15494.59
Suven Pharma (BSE)
up  1159.80 (4.55%)
M.Cap ( in Cr)29524.44
MORE
Shareholding Pattern
NON-INSTITUTION 8.93%
PROMOTERS 54.48%
FI/BANKS/INSURANCE 4.79%
MUTUAL FUNDS/UTI 12.24%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
MORE
FAQs
079-49005200 / 01 / 02
info@ratnakarsecurities.com
Download Mobile App

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
products
about us
usefull links
news room

Ratnakar Securities Pvt. Ltd. : SEBI Registration No. of NSE, BSE : INZ000191735 | SEBI Registration No. of NSDL : IN-DP-NSDL-66-88
Ratnakar Commodities Pvt. Ltd : SEBI Registration No. of MCX & NCDEX : INZ000024138
Investor Grievance ID : investorgrievance@ratnakarsecurities.com
Online Dispute Resolution Portal - SMART ODR
To File A Complaint on SCORES Click Here
To Close Account, Please Click Here
For Nomination, Please Click Here
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.